Jellagen announced a partnership with Copner Biotech to develop the world’s first Jellyfish bio-ink/hydrogels for tissue regeneration.
Tel Aviv University researchers successfully 3D bioprinted an active tumour to achieve a scientific breakthrough in battle against cancer.
Sensing the impact of 3D printing on the healthcare sector and the future implications of the technology, the Andhra Pradesh MedTech Zone (AMTZ), on the 8th of March, 2021, inaugurated its 3D Bioprinting facility to develop artificial organs through 3D Bioprinting under the Bio Harmonised Aids for Rehabilitation and Treatment (BHARAT) programme to boost diagnostics and therapy.
CELLINK, the leading bioconvergence company in the world, announced the launch of the BIO MDX™ Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices.
Cellink Announces Strategic Partnership with Kugelmeiers Ltd. for 3D Printing Cell Spheroid Kits
2 Mins read
CELLINK announced a distribution partnership with Kugelmeiers Ltd. to bring to market CELLINK’s 3D Printing Cell Spheroid Kits.
Last week KFC, the American fast food restaurant chain, announced that it has partnered with 3D Bioprinting Solutions, a Laboratory for Biotechnological Research in Russia, to develop its innovative concept of creating a “Restaurant of the Future”. This futuristic restaurant will offer 3D bioprinted chicken nuggets in Russia.
CELLINK, a global leader in developing and delivering life-science solutions, has joined forces with Lonza, the Swiss Chemicals and Biotechnology Company, to offer a comprehensive 3D Bioprinting solution designed to advance complete 3D cell culture workflows.
"3D Printing to Play Major Role in Mitigating Spread of COVID-19" Say Researchers from VIT
5 Mins read
3D bioprinting technology might play an important role in the aid of curtailing this pandemic. A potential future direction that employs 3D bioprinting can involve the replacement of defective organs due to viral infection. This article sees how 3D printing can play a major role in mitigating the spread of COVID-19.
Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 million Series-A financing round. Radical…
3D Systems, one of the largest 3D printing companies in the world has joined forces with CollPlant Biotechnologies a developer of proprietary…
